BioHarvest Sciences Inc. Stock Canadian Securities Exchange
Stocks
BHSC
CA13767B1013
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3500 CAD | +6.06% |
|
-2.94% | +46.67% |
| Market Cap | 72.54M 62.65M 57.73M 54.04M 101M 6.89B 103M 682M 266M 3.36B 272M 266M 11.62B | P/E Ratio 2026 * |
-7.85x | P/E Ratio 2027 * | -19.4x |
|---|---|---|---|---|---|
| Enterprise Value | 72.54M 62.65M 57.73M 54.04M 101M 6.89B 103M 682M 266M 3.36B 272M 266M 11.62B | EV / Sales 2026 * |
1.69x | EV / Sales 2027 * | 1.23x |
| Free-Float |
85.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioHarvest Sciences Inc.
| 1 day | +6.06% |
| Manager | Title | Age | Since |
|---|---|---|---|
Zaki Rakib
CEO | Chief Executive Officer | 68 | 2026-04-28 |
Bar Dichter
DFI | Director of Finance/CFO | - | 2024-10-27 |
Ilana Belzer
COO | Chief Operating Officer | 65 | 2023-04-18 |
| Director | Title | Age | Since |
|---|---|---|---|
Zaki Rakib
CHM | Chairman | 68 | 2018-09-26 |
Vivien Rakib
BRD | Director/Board Member | 67 | 2018-09-26 |
Jake Fiddick
BRD | Director/Board Member | 84 | 2019-02-06 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.06% | -2.94% | - | - | 72.54M | |
| +0.10% | +3.67% | -10.44% | -4.62% | 13.34B | |
| +2.67% | -0.32% | -32.02% | -55.44% | 5.06B | |
| +0.90% | +1.77% | -6.31% | +4.08% | 4.79B | |
| +3.15% | +2.01% | +8.20% | -40.81% | 3.88B | |
| +2.11% | -2.30% | +13.25% | -18.51% | 3.86B | |
| +2.81% | -3.14% | -1.45% | -6.39% | 3.69B | |
| +1.48% | +1.55% | -10.11% | -1.44% | 3.18B | |
| +5.11% | +1.13% | -8.04% | -26.93% | 2.37B | |
| +0.87% | -4.27% | -11.89% | +29.70% | 1.73B | |
| Average | +2.53% | +1.23% | -6.53% | -13.37% | 4.66B | |
| Weighted average by Cap. | +1.64% | +1.67% | -7.77% | -14.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 42.89M 37.04M 34.14M 31.95M 59.88M 4.08B 60.81M 403M 157M 1.98B 161M 158M 6.87B | 58.96M 50.92M 46.92M 43.92M 82.31M 5.6B 83.59M 554M 216M 2.73B 221M 217M 9.44B |
| Net income | -9.27M -8M -7.37M -6.9M -12.94M -881M -13.14M -87.08M -33.95M -429M -34.77M -34.03M -1.48B | -3.77M -3.26M -3M -2.81M -5.27M -359M -5.35M -35.46M -13.83M -175M -14.16M -13.86M -604M |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BHST Stock
- BHSC Stock
Select your edition
All financial news and data tailored to specific country editions
